Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Hydrocortisone vs Dexamethasone for Conjunctival Inflammatory Secretions in Ocular Prosthesis
2021-003794-56Phase 3Active
- Sponsor
- CHU Rennes
- Start
- Sep 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of hydrocortisone and dexamethasone in conjunctivitis (3 arms), sponsored by CHU Rennes. Primary endpoint: Secretion Self-Rating Scale score. Started Sep 2024; status: active.
02
Drugs
hydrocortisonedexamethasone
03
Conditions
conjunctivitis
Beyond the preview
Go deeper on 2021-003794-56.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-003794-56.